Lutetium Oxodotreotide Lu-177 vs Trastuzumab
Lutetium Oxodotreotide Lu-177 vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Lutetium Oxodotreotide Lu-177 and Trastuzumab.
Mechanism of Action
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Trastuzumab — 28 days.
Chemical Properties
Type: Lutetium Oxodotreotide Lu-177 — Protein; Trastuzumab — Antibody.